To confirm the utility of the VCAN gene as a marker for distinguishing LVI(+) and LVI(−) in clinical samples, we conducted an experiment that analyzed VCAN RNA expression in 36 stage III UTUC tumors, including 17 LVI(+) and 19 LVI(−) patients. Here, VCAN is linked to renal pelvis/ureter urothelial carcinoma.